BIOMIND LABS INC. (3XI) — Financial Flexibility Index
BIOMIND LABS INC. (3XI) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of €-38.70K (operating CF €-38.70K minus capex €0.00) represents 0% of total liabilities (€1.62 Million). Also explore how fast is BIOMIND LABS INC. growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BIOMIND LABS INC. Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for BIOMIND LABS INC. across 4 annual periods. See 3XI equity to assets ratio to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for BIOMIND LABS INC. (2021–2024)
Year-by-year free cash flow to debt coverage for BIOMIND LABS INC.. For the full company profile including market capitalisation, see 3XI stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.26x | €-354.43K | €-354.43K | €1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | €-765.93K | €-765.93K | €1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | €-2.15 Million | €-2.15 Million | €336.72K | ▼ -3.0% |
| 2021 | -6.20x | €-2.08 Million | €-2.12 Million | €334.95K | — |